Serum Uromodulin and DN Systematic Review and Meta Analysis
NCT ID: NCT06596863
Last Updated: 2024-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1774 participants
OBSERVATIONAL
2024-05-01
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Renal Resisitive Index as an Indicator of the Progression of Diabetic Nephropathy
NCT03658317
The Association Between sUCR and the Survival in Patients With DKD
NCT04612595
Predictors of Survival of DKD Patients in Assiut University Hospital
NCT06865456
Prevention In Community Clinics From Diabetic Kidney Disease
NCT04988581
CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy
NCT05681286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Included 862 healthy subjects as control group
The association of serum uromodulin with DN
Meta analysis of association of serum uromodulin with DKD
The DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
DKD group
Included 912 patients with DN
The association of serum uromodulin with DN
Meta analysis of association of serum uromodulin with DKD
The DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
The association of serum uromodulin with DN
Meta analysis of association of serum uromodulin with DKD
The DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
DN patients were divided according to the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. serum level of uromodulin was determined;
2. the samples were enrolled from diabetic patients;
3. mean ± SD was reported for uromodulin between patients with and without DN;
4. the level of albumin to creatinine ratio (ACR), glomerular filtration rate (GFR), or albumin excretion rate (AER) in patients with DN was determined
Exclusion Criteria
1. duplicate studies;
2. review articles;
3. non original research articles;
4. studies with insufficient data to extract;
5. non-human research;
6. studies that determined urine level of uromodulin.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shaimaa Ibrahim Barr
Dr of Biochemistry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta Yniversity
Tanta, Yes, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DKD serum uromodulin
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.